Skip to main content

Table 1 Study inclusion and exclusion criteria

From: Improving the quality and efficiency of follow-up after curative treatment for breast cancer – rationale and study design of the MaCare trial

Inclusion criteria
• Female patients with breast cancer without distant metastases
• WHO performance scale 0–2
• Treated with curative intent (i.e. lumpectomy or mastectomy, with or without radiotherapy and/or chemotherapy)
• Treatment completed < 6 weeks prior to randomisation
• Able to speak and read fluently in Dutch
 
Exclusion criteria
• Participation in another trial, requiring more frequent follow-up
• Medical diseases (treatment-related side-effects, concomitant tumours) requiring frequent follow-up